300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Hospitality
Legal
eSports
Biotechnology
Construction
Consumer
Renewable Energy
Software
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Fashion
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Social
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Beauty
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Infrastructure
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Bangladesh
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Duan Xufang

Partner @ Qianhai Fund of Funds

Duan Xufang is a Series A investor at Qianhai Fund of Funds focused on Medical and Health Care. is partner of Qianhai Fund of Funds.

Total investments:
3
Last investment:
Lead investor:
100%

Last updated:

Industries Duan Xufang invests in

MedicalHealth CareBiotechnologyRoboticsBiopharma

Stages Duan Xufang invests in

Series ASeries BPrivate Equity

Countries Duan Xufang invests in

China

Investment Focus

Industry

  • Medical 2 (67%)
  • Health Care 2 (67%)
  • Biotechnology 2 (67%)
  • Robotics 1 (33%)
  • Biopharma 1 (33%)
See all 7 industries →

Stage

  • Series A 1 (33%)
  • Series B 1 (33%)
  • Private Equity 1 (33%)

Investments

CompanyDescriptionRoundLinks
Aoda Zhisheng Aoda Zhisheng
Aoda Zhisheng provides clinical robot systems, technology, and smart medical comprehensive solutions. Series A / Nov 01, 2024
Hebei Senlang Biotechnology Hebei Senlang Biotechnology
Hebei Senlang Biotechnology is focused on the treatment of immune cells new technology development and application of high-tech enterprises.The company has the CAR-T research base (Senrang CAR-T Research Center) in North China, and has formed a high-barrier technology platform such as innovative CAR structural design, virus and cell culture , whichcan take into account technical research and development, hospital clinical application Provide high-quality and effective cellular immunotherapy support for hematological tumors, solid tumors and other tumor diseases, immune system diseases and other patients. $29.6M / Private Equity / May 18, 2022
Resproly Resproly
Resproly is a research and development, production and sales of formula and equipment for respiratory inhalation. An integrated enterprise that focuses on multiple clinically demanding treatment areas such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), Diabetes, and Parkinson's Disease. Series B / Apr 30, 2022

Co-Investors

Qianhai Fund of Funds

About Qianhai Fund of Funds

VC Fund · Shanzhen, China

Qianhai Fund of Funds is a fund management company that markets qualified investors in the private equity investment industry. Qianhai Fund of Funds comes from four types of LP's such as local governments, well-known companies, insurance financial institutions, and a number of listed companies and well-known corporate controllers. The fundmanagement party introduced at the press conference that the Qianhai Fund of Funds' overall investment strategy pursues low-risk, medium-to-high-yield, mainly based on high-quality venture capital, and private equity investment funds, supplemented by direct investment and short-term investment.Qianhai Fund of Funds was founded on 2015 and is headquartered in Shenzhen, China.

Qianhai Fund of Funds Contacts

NameEmailPhoneSocials
Ang Gao
Ang Gao Managing Partner
Duan Xufang Partner
Haitao Yan
Haitao Yan Chief Executive Partner
Hugo Shong
Hugo Shong Joint Partner
Li Peng Managing Director

Sign up to unlock verified contacts

Unlock Contacts
Open Qianhai Fund of Funds full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Hospitality
Legal
eSports
Biotechnology
Construction
Consumer
Renewable Energy
Software
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Fashion
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Social
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Beauty
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Infrastructure
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Bangladesh
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Duan Xufang invest in?

Duan Xufang invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Duan Xufang last invest?

The most recent investment recorded for Duan Xufang closed in Nov 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Duan Xufang Find email